| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/08/2023 | 300.64% | HC Wainwright & Co. | → $25 | Reiterates | → Buy |
| 01/05/2023 | 140.38% | EF Hutton | → $15 | Initiates Coverage On | → Buy |
| 07/25/2022 | 300.64% | HC Wainwright & Co. | → $25 | Initiates Coverage On | → Buy |
| 01/13/2022 | 236.54% | Maxim Group | → $21 | Initiates Coverage On | → Buy |
What is the target price for Genenta Science (GNTA)?
The latest price target for Genenta Science (NASDAQ: GNTA) was reported by HC Wainwright & Co. on February 8, 2023. The analyst firm set a price target for $25.00 expecting GNTA to rise to within 12 months (a possible 300.64% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Genenta Science (GNTA)?
The latest analyst rating for Genenta Science (NASDAQ: GNTA) was provided by HC Wainwright & Co., and Genenta Science reiterated their buy rating.
When is the next analyst rating going to be posted or updated for Genenta Science (GNTA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Genenta Science, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Genenta Science was filed on February 8, 2023 so you should expect the next rating to be made available sometime around February 8, 2024.
Is the Analyst Rating Genenta Science (GNTA) correct?
While ratings are subjective and will change, the latest Genenta Science (GNTA) rating was a reiterated with a price target of $0.00 to $25.00. The current price Genenta Science (GNTA) is trading at is $6.24, which is within the analyst's predicted range.